Direct interaction between causative genes of DYT1 and DYT6 primary dystonia

Annals of Neurology

Volumn 68, Issue 4, 2010, Pages 549-553

  Gavarini, Sophie ^a   Cayrol, Corinne ^b,c   Fuchs, Tania ^a   Lyons, Natalia ^a   Ehrlich, Michelle E ^a   Girard, Jean Philippe ^b,c   Ozelius, Laurie J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; DNA SEQUENCE; DYSTONIA; ELECTROMOBILITY SHIFT ASSAY; ENDOTHELIUM CELL; GENE; GENE IDENTIFICATION; GENE INTERACTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIMARY DYSTONIA; PRIORITY JOURNAL; THAP1 GENE; TOR1A GENE; UMBILICAL VEIN; ADULT; AGED; ANIMAL; BRAIN; CELL CULTURE; CELL NUCLEUS; DRUG EFFECT; DYSTONIC DISORDER; FEMALE; FIBROBLAST; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MOUSE; MUTATION; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; PROTEIN BINDING; ULTRASTRUCTURE;

APOPTOSIS REGULATORY PROTEIN; CHAPERONE; DNA BINDING PROTEIN; MESSENGER RNA; NUCLEAR PROTEIN; SMALL INTERFERING RNA; THAP1 PROTEIN, HUMAN; TOR1A PROTEIN, HUMAN;

ADULT; AGED; ANIMALS; APOPTOSIS REGULATORY PROTEINS; BRAIN; CELL NUCLEUS; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; DYSTONIC DISORDERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIAL CELLS; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; GLIOBLASTOMA; HUMANS; MALE; MICE; MIDDLE AGED; MOLECULAR CHAPERONES; MUTATION; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION; UMBILICAL VEINS;

EID: 78149483955     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22138     Document Type: Article

References (24)

1. Fuchs T, Gavarini S, Saunders-Pullman R, et al. Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia. Nat Genet 2009; 41: 286 288.
2. Bressman SB, Raymond D, Fuchs T, et al. Mutations in THAP1 (DYT6) in early-onset dystonia: a genetic screening study. Lancet Neurol 2009; 8: 441 446.
3. Djarmati A, Schneider SA, Lohmann K, et al. Mutations in THAP1 (DYT6) and generalised dystonia with prominent spasmodic dysphonia: a genetic screening study. Lancet Neurol 2009; 8: 447 452.
4. Houlden H, Schneider SA, Paudel R, et al. THAP1 mutations (DYT6) are an additional cause of early-onset dystonia. Neurology 2010; 74: 846 850.
5. Xiao J, Zhao Y, Bastian RW, et al. Novel THAP1 sequence variants in primary dystonia. Neurology 2010; 74: 229 238.
6. Bonetti M, Barzaghi C, Brancati F, et al. Mutation screening of the DYT6/THAP1 gene in Italy. Mov Disord 2009; 24: 2424 2427.
7. Paisan, -Ruiz C, Ruiz-Martinez J, Ruibal M, et al. Identification of a novel THAP1 mutation at R29 amino-acid residue in sporadic patients with early-onset dystonia. Mov Disord 2009; 24: 2428 2429.
8. Roussigne M, Kossida S, Lavigne AC, et al. The THAP domain: a novel protein motif with similarity to the DNA-binding domain of P element transposase. Trends Biochem Sci 2003; 28: 66 69.
9. Clouaire T, Roussigne M, Ecochard V, et al. The THAP domain of THAP1 is a large C2CH module with zinc-dependent sequence-specific DNA-binding activity. Proc Natl Acad Sci U S A 2005; 102: 6907 6912.
10. Bessiere D, Lacroix C, Campagne S, et al. Structure-function analysis of the THAP zinc finger of THAP1, a large C2CH DNA-binding module linked to Rb/E2F pathways. J Biol Chem 2008; 283: 4352 4363.
11. Sabogal A, Lyubimov AY, Corn JE, et al. THAP proteins target specific DNA sites through bipartite recognition of adjacent major and minor grooves. Nat Struct Mol Biol 2010; 17: 117 123.
12. Cayrol C, Lacroix C, Mathe C, et al. The THAP-zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cell-cycle target genes. Blood 2007; 109: 584 594.
13. Armata IA, Ananthanarayanan M, Balasubramaniyan N, Shashidharan P., Regulation of DYT1 gene expression by the Ets family of transcription factors. J Neurochem 2008; 106: 1052 1065.
14. Vasudevan A, Breakefield XO, Bhide PG,. Developmental patterns of torsinA and torsinB expression. Brain Res 2006;1073-1074: 139 145.
15. Jungwirth M, Dear ML, Brown P, et al. Relative tissue expression of homologous torsinB correlates with the neuronal specific importance of DYT1 dystonia-associated torsinA. Hum Mol Genet 2010; 19: 888 900.
16. Chong JL, Wenzel PL, Saenz-Robles MT, et al. E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells. Nature 2009; 462: 930 934.
17. Montemayor C, Montemayor OA, Ridgeway A, et al. Genome-wide analysis of binding sites and direct target genes of the orphan nuclear receptor NR2F1/COUP-TFI. PLoS One 2010; 5: e8910.
18. Wichmann T,. Commentary: dopaminergic dysfunction in DYT1 dystonia. Exp Neurol 2008; 212: 242 246.
19. Carbon M, Eidelberg D,. Abnormal structure-function relationships in hereditary dystonia. Neuroscience 2009; 164: 220 229.
20. Peterson DA, Sejnowski TJ, Poizner H,. Convergent evidence for abnormal striatal synaptic plasticity in dystonia. Neurobiol Dis 2010; 37: 558 573.
21. Vasques X, Cif L, Gonzalez V, et al. Factors predicting improvement in primary generalized dystonia treated by pallidal deep brain stimulation. Mov Disord 2009; 24: 846 853.
22. Ma'ayan A, Jenkins SL, Goldfarb J, Iyengar R,. Network analysis of FDA approved drugs and their targets. Mt Sinai J Med 2007; 74: 27 32.
23. Roussigne M, Cayrol C, Clouaire T, et al. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies. Oncogene 2003; 22: 2432 2442.
24. Mazars R, Gonzalez-de-, Peredo A, Cayrol C, et al. The THAP-zinc finger protein thap1 associates with coactivator HCF-1 and O-GLcNAc transferase: A link between DYT6 and DYT3 dystonias. J Biol Chem 2010; 285: 13364 13371.